Emergent Biosolutions Inc (EBS)
Financing Cash Flow
-$165.60M
TTM · Period ending: · USD
EBS Financing Cash Flow
Latest reported-$165.60Mperiod ending
Latest reported-$165.60Mperiod ending
EBS TTM Cash from Financing ($18.49M → -$165.60M)
TTM financing cash flow
High-resolution chart · PNG
EBS financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -165,600,000 | |
| -147,600,000 | |
| -136,600,000 | |
| -22,200,000 | |
| -186,600,000 | |
| -231,100,000 | |
| -190,000,000 | |
| -185,800,000 | |
| -48,500,000 | |
| -484,500,000 | |
| -535,700,000 | |
| -187,300,000 | |
| 85,000,000 | |
| 541,200,000 | |
| 481,200,000 | |
| 18,100,000 | |
| -216,200,000 | |
| -189,300,000 | |
| -141,000,000 | |
| -33,300,000 | |
| 58,800,000 | |
| 67,300,000 | |
| 69,500,000 | |
| 13,900,000 | |
| -92,900,000 | |
| 2,500,000 | |
| -35,900,000 | |
| 807,980,000 | |
| 829,357,000 | |
| 732,425,000 | |
| 788,700,000 | |
| -31,426,000 | |
| -28,416,000 | |
| -30,819,000 | |
| -51,401,000 | |
| -15,476,000 | |
| -64,578,000 | |
| -49,977,000 | |
| -18,641,000 | |
| -7,448,000 | |
| 40,043,000 | |
| 31,082,000 | |
| 33,449,000 | |
| 24,166,000 | |
| 21,492,000 | |
| 16,996,000 | |
| 198,874,000 | |
| 202,695,000 | |
| 202,940,000 | |
| 200,491,000 | |
| 8,612,000 | |
| -248,000 | |
| -1,679,000 | |
| -40,000 | |
| -1,765,000 | |
| -2,869,000 | |
| 12,262,000 | |
| 10,126,000 | |
| 14,251,000 | |
| 19,668,000 | |
| 6,128,000 | |
| -6,837,000 | |
| -9,358,000 | |
| 14,371,000 | |
| 1,694,000 | |
| 15,530,000 | |
| 14,844,000 | |
| -8,956,000 | |
| 7,398,000 | |
| 6,864,000 | |
| 8,968,000 | |
| 11,183,000 | |
| 21,110,000 | |
| 27,682,000 | |
| 18,491,000 | |
| 75,019,000 |